ST8SIA3: ST8 Alpha-N-Acetyl-Neuraminide Alpha-2,8-Sialyltransferase 3

A sialyltransferase involved in ganglioside biosynthesis and neural development.

Gene Information Card

Symbol ST8SIA3
Full Name ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3
Gene Type protein-coding
Chromosomal Location 18q21.33
NCBI Gene ID 51046 ncbi.nlm.nih.gov/gene/51046
Ensembl ID ENSG00000177570
UniProt ID Q9H4F1
OMIM ID 608115
HGNC ID 10869
Aliases SIAT8C, ST8SiaIII, GD3S, GT3S

Description

ST8SIA3 encodes a member of the glycosyltransferase family 29, specifically a sialyltransferase that catalyzes the transfer of sialic acid from CMP-sialic acid to acceptor substrates. This enzyme is responsible for the synthesis of gangliosides GD3 and GT3, which are critical for neural cell differentiation, axon growth, and synaptic plasticity. Expression is predominantly in the brain and testis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Ganglioside storage disorders (e.g., GM1 gangliosidosis, Sandhoff disease) Altered ganglioside metabolism due to dysregulation of ST8SIA3 activity may contribute to substrate accumulation. Inferred from pathway involvement; direct evidence limited.
Neuroblastoma Overexpression of ST8SIA3 leads to increased GD3 synthesis, promoting tumor cell proliferation and migration. COSMIC; PMID: 21947068
Colorectal cancer Aberrant ST8SIA3 expression correlates with poor prognosis and altered sialylation patterns. COSMIC; PMID: 25695633

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 High
Testis 8.2 Medium
Adrenal gland 3.1 Low
Lung 1.0 Not detected
Liver 0.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 15.3 High expression; used in neural differentiation studies
SK-N-SH (neuroblastoma) 11.8 High expression
HEK293 (embryonic kidney) 0.2 Very low expression
HeLa (cervical carcinoma) 0.1 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) missense <0.01% Likely loss of start codon; predicted loss of function
c.104C>T (p.Pro35Leu) missense <0.01% Unknown significance; not in ClinVar
c.682G>A (p.Gly228Arg) missense <0.01% Unknown significance; not in ClinVar
Mutation functional classification

Loss of Function (LOF)

No confirmed loss-of-function mutations reported in ClinVar or COSMIC.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported.

Dominant Negative (DN)

No evidence for dominant-negative effects.

Pathways

• Ganglioside biosynthesis (Reactome: R-HSA-1660662)
• Sphingolipid metabolism (KEGG: hsa00600)
• Glycosphingolipid biosynthesis - lacto and neolacto series (KEGG: hsa00601)

Protein Summary

ST8SIA3 is a 375-amino acid type II transmembrane protein localized to the Golgi apparatus. It catalyzes the alpha-2,8-sialylation of GM3 to form GD3, and of GD3 to form GT3. The protein contains a short N-terminal cytoplasmic tail, a transmembrane domain, and a large C-terminal catalytic domain facing the Golgi lumen. Its expression is tightly regulated during neural development.

Related Products

Product name Cat.No. Species Gene ID
ST8SIA3 Knockout HEK293 Cell Line EDJ-KQ10890 Human 51046 Details Get a Quote
ST8SIA3 Knockout HeLa Cell Line EDJ-KQ56218 Human 51046 Details Get a Quote
ST8SIA3 Knockout A-549 Cell Line EDJ-KQ64709 Human 51046 Details Get a Quote
ST8SIA3 Knockout HCT 116 Cell Line EDJ-KQ73155 Human 51046 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: